Vitamin B12 and Pernicious Anaemia: Diagnosis and Management

Vitamin B12 (cobalamin) is a complex, essential nutrient that acts as the linchpin for several critical physiological processes. It is required for the synthesis of DNA, the formation of healthy red blood cells, and the maintenance of the myelin sheath—the protective coating that surrounds our nerves. When B12 levels fall, the consequences can be severe, ranging from debilitating fatigue to irreversible neurological damage.

Unlike many other vitamins, the body's ability to absorb B12 is incredibly complex and fragile. As a clinician, I frequently see patients who consume plenty of B12 in their diet (found exclusively in animal products like meat, dairy, and eggs) but are still profoundly deficient. To understand why, we must look at the mechanics of absorption and a specific autoimmune condition known as Pernicious Anaemia.

The Complex Journey of B12 Absorption

When you eat a steak or an egg, the B12 is bound to the protein in the food. The absorption process involves several distinct steps:

1. Stomach Acid: Hydrochloric acid and an enzyme called pepsin in the stomach must first unbind the B12 from the food protein.
2. Intrinsic Factor: Crucially, the parietal cells in the stomach lining must secrete a specialized protein called Intrinsic Factor (IF).
3. The Binding: The free B12 travels to the small intestine, where it must bind to the Intrinsic Factor.
4. Absorption: This B12-IF complex travels to the very end of the small intestine (the terminal ileum), where specific receptors recognize the Intrinsic Factor and absorb the B12 into the bloodstream.

If any single step in this chain is broken—due to low stomach acid (common with age or antacid use), gastrointestinal surgery, or intestinal inflammation (like Crohn's disease)—B12 deficiency will occur, regardless of diet.

Pernicious Anaemia: An Autoimmune Attack

Pernicious Anaemia is the most common cause of severe B12 deficiency in the UK. It is not a dietary issue; it is an autoimmune disease. In Pernicious Anaemia, the immune system mistakenly produces antibodies that attack either the parietal cells in the stomach (stopping the production of Intrinsic Factor) or the Intrinsic Factor itself.

Without Intrinsic Factor, the body simply cannot absorb B12 from food or standard oral supplements. The B12 passes straight through the digestive tract. The term "pernicious" means deadly or destructive, reflecting the fact that before the discovery of B12 injections, this condition was fatal.

Clinical Symptoms and Diagnosis

Because the liver can store a several-year supply of B12, symptoms of deficiency often develop very slowly and insidiously. They typically manifest in two main areas:

• Haematological (Blood): B12 is needed to make red blood cells. Without it, the body produces abnormally large, inefficient red blood cells (macrocytic anaemia). This leads to severe fatigue, breathlessness, and pale skin.
• Neurological (Nerves): B12 deficiency damages the myelin sheath. Symptoms include tingling or numbness in the hands and feet (peripheral neuropathy), brain fog, memory loss, and balance issues. Crucially, neurological damage can occur even if anaemia is not yet present, and if left untreated, it can become permanent.

Testing and Management

Diagnosing the root cause is essential. A standard "Active B12" blood test will confirm the deficiency. However, to diagnose Pernicious Anaemia, we must test for Intrinsic Factor Antibodies and Gastric Parietal Cell Antibodies.

If Pernicious Anaemia or severe malabsorption is diagnosed, dietary changes and standard oral supplements will not work. The patient requires lifelong B12 injections (usually hydroxocobalamin) administered directly into the muscle, bypassing the digestive system entirely to ensure the body receives this vital nutrient.

Medical References

1. National Institute for Health and Care Excellence (NICE). (2023). Anaemia - B12 and folate deficiency. Clinical Knowledge Summaries.
2. Stabler, S. P. (2013). Vitamin B12 deficiency. New England Journal of Medicine, 368(2), 149-160.
3. British Society for Haematology. (2014). Guidelines for the diagnosis and treatment of cobalamin and folate disorders.